Moreover, TAMs isolated from fresh CRC tissues were shown to have higher levels of IL-10, CCL17, and TGF- β1 in KRAS mutant patients as opposed to KRAS wild-type counterparts (Fig. 2d). This evidence concerns the gene KRAS and colorectal carcinoma.